Head of Technical Operations Ig/Inframarginals, Recombinants, Vaccines and Iron

The Technical Operations Head will oversee a cluster of related cross-functional, autonomous Integrated Product Teams (IPTs) each responsible for the end-to-end technical projects within a defined product group and supporting business as usual activities at our manufacturing sites. This role is critical to managing top-level priorities, dynamic resourcing, and the full portfolio of initiatives in a regulated pharmaceutical environment. Operates within a standardized governance framework and interfaces directly with leadership team.

Responsibilities:

• Accountable for project delivery and site support across all IPTSs in direct reporting line

• Maintain dynamic resourcing through approving inter-IPT resource transfers and ensuring that cross-IPT resources are deployed to best enable portfolio delivery

• Set the operational performance targets (KPIs) for IPTSs and monitoring their progress, addressing any lagging KPIs as needed, while ensuring adherence to budget

• Support the COO and Technical Operations Committee in evaluating and prioritizing major Technical Operations projects, then assigns approved projects to the relevant IPT

• Provide support to address any issues escalated from IPTSs in direct reporting line

• Work closely together with the Technical Operations Head: ZAPP / Albumin IPTs to ensure consistency in project delivery and resource sharing across all IPTs in the organization

• Manage the IPT Leads and provides guidance as needed, ensuring strong development of leadership talent

• Ensure that the strategic vision for Technical Operations bridges from the COO to the IPTs

• Expected to serve as a change leader for the Technical Operations organization

Qualifications:

• Bachelor’s degree in a relevant scientific or technical field (e.g., Pharmaceutical Sciences, Chemical or Biomedical Engineering, Biotechnology, Biology/Chemistry, etc.)
• Advanced degree (MS or PhD) in a related field strongly preferred

• 15+ years of professional experience in the biopharma, biotech, or life sciences industry with deep exposure to leading teams through drug development and full-scale manufacturing, such as drug product formulation, late-stage clinical or commercial manufacturing, technical transfer, CMC processes, or day-to-day technical support of full-scale manufacturing facilities

• Strength in portfolio-level oversight, balancing strategic priorities, resource allocation, and risk across multiple programs and therapeutic platforms to maximize enterprise value
• Deep fluency in portfolio governance models, including scenario planning and value-based prioritization of initiatives
• Skilled at financial management, the ability to assess tradeoffs, monitor portfolio-level performance metrics, and guide funding decisions to ensure ROI and long-term sustainability
• Effective global communicator, with experience presenting complex information to executive stakeholders and diverse teams across time zones
• Demonstrated ability to develop high-performing leaders, with a focus on coaching IPT Leads to elevate strategic thinking, enterprise mindset, and cross-functional influence
• Adept at leveraging analytics and insights to inform strategic decisions, drive portfolio transparency, and continuously improve operating models

Different qualifications or responsibilities may apply based on local legal and/or educational requirements. Refer to local job documentation where applicable.

Our Benefits

We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma . Our parent company, CSL , headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

We want CSL to reflect the world around us

At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Inclusion and Belonging | CSL .

Do work that matters at CSL Behring!